No AI summary for this filing type
View Full Filing (SEC EDGAR)Akebia Therapeutics INC
-$48.7M
Net Activity
Institutions Holding
172
Popularity Rank
#3259
Avg Weight
0.01%
Total Value
$141.7M
Ownership Trend
172 institutions currently hold AKBA, with 71 net buyers and 83 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
83
Net Buying Institutions
71
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$39.2M
Total Buy Value
$127.2M
Total Sell Value
71
Net Buyers
83
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
1
Filings (90d)
$62K
Total Est. Value
56K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Ostrowski Erik | 2026-06-29 | $62K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
FAQ
Who are the top institutional investors holding AKEBIA THERAPEUTICS INC (AKBA)?
What is the overall institutional sentiment toward AKBA recently?
Which institutions have been selling or reducing their AKBA positions?
Are there any notable investors adding AKBA to their portfolios?
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
Microsoft CORP
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Amazon.com INC
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Nvidia CORP
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter